The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differential genomic profiling of the progesterone receptor (PR) negative and estrogen receptor (ER) low metastatic breast cancer subtypes through circulating tumor DNA: A TNBC-like disease subtype?
 
Lorenzo Gerratana
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Incyte; Lilly; Novartis
Research Funding - AstraZeneca (Inst)
 
Andrew A. Davis
Consulting or Advisory Role - bioTheranostics; Pfizer
 
Lorenzo Foffano
No Relationships to Disclose
 
Carolina Reduzzi
No Relationships to Disclose
 
Emily L Podany
No Relationships to Disclose
 
Arielle J Medford
No Relationships to Disclose
 
Katherine Clifton
Employment - Zing Health (I)
Stock and Other Ownership Interests - Centene (I); WellCare (I)
Consulting or Advisory Role - bioTheranostics; Pfizer
 
Marko Velimirovic
Stock and Other Ownership Interests - Abbvie; Amgen
 
Annika Putur
No Relationships to Disclose
 
Laura Sofia Munoz-Arcos
No Relationships to Disclose
 
Letizia Pontolillo
No Relationships to Disclose
 
Shaili Tapiavala
No Relationships to Disclose
 
Elisabetta Molteni
No Relationships to Disclose
 
Eleonora Nicolò
No Relationships to Disclose
 
William John Gradishar
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Gilead Sciences; merck; Novartis; Pfizer
 
Cynthia X. Ma
Consulting or Advisory Role - AstraZeneca; Biovica; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Genzyme; Gilead Sciences; Lilly; Novartis; Olaris; Pfizer; Regor Therapeutics Group; Stemline Therapeutics; Tempus; Tersera; Tersera
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate: Authorship - served as a co-author on the subject of endocrine therapy for metastatic breast cancer and receive compensation as an author, less than a few hundred dollars a year. It does not affect my patient care or research.
Travel, Accommodations, Expenses - SABCS; Total Health Conferencing
 
Eleni Andreopoulou
No Relationships to Disclose
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/Daiichi Sankyo; Eisai; Gilead Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Viatris
Research Funding - AstraZeneca; Eisai; Roche
 
Aditya Bardia
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Genentech; Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly; Lilly (Inst); Menarini; Menarini (Inst); Merck; Mersana; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health (Inst); Sanofi
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Massimo Cristofanilli
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Celcuity; Lilly; Menarini; Olaris; Sermonix Pharmaceuticals; Syantra
Research Funding - Angle; AstraZeneca; Lilly; Menarini Silicon Biosystems; Merck